In this post we are going to see multiyear breakout stocks of sept-2024. Today I am going to share two stocks which are giving multiyear breakout. The first is Bajaj Finserv and another one is Thyrocare. Both stocks are fundamentally strong and technically looking good on the charts.
Bajaj Finserv:
Bajaj finserv is looking good on chart and after a long consolidation now its breaking resistance with a good volume. Stock current market price is 1783 and already it has broken trendline resistance. If you get this stock in a range of 1700-1730 then this will be best entry and we can keep stoploss at 1500. The targets are 2500, 3000 and 3300. please make sure if stock goes below 1500 then the chart will no more stronger so you have to exit your position.
Thyrocare:
Thyrocare Technologies is a leading diagnostic and preventive healthcare services provider in India, known for its focus on affordable, high-quality diagnostic tests. The company’s stock has attracted investor interest due to its strong market presence, asset-light business model, and extensive network of diagnostic labs. Thyrocare’s focus on automation and technology-driven operations allows it to maintain competitive pricing and high margins, making it a profitable player in the diagnostics space. However, the stock is influenced by factors such as competition, regulatory changes, and evolving consumer preferences in healthcare, requiring investors to stay vigilant about industry trends and innovations.
The current price of stock is 840 and it has given multiyear breakout with volume. Best buying zone is 700-750, if you get this price in future then you can consider it for buying. If this stock breaks the 555 level then the stock will be weak in chart. so you can keep your stoploss at 555 level. The first target is 1200 and another is 1400.
Before investing in these stocks please do your own research or take advise from your financial consultant. If you are more interested in trading then click here or if you want to know more about investment then click here.